PubMed

Adherence to protease inhibitor therapy and outcomes in patients with HIV infection.

Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, Wagener MM, Singh N.

Ann Intern Med. 2000 Jul 4;133(1):21-30. Erratum in: Ann Intern Med 2002 Feb 5;136(3):253. PMID: 10877736 [PubMed - indexed for MEDLINE]Related articlesFree article

Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes.

Nachega JB, Hislop M, Dowdy DW, Chaisson RE, Regensberg L, Maartens G.

Ann Intern Med. 2007 Apr 17;146(8):564-73.PMID: 17438315 [PubMed - indexed for MEDLINE]Related articlesFree article

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.PMID: 11813503 [PubMed - indexed for MEDLINE]Related articles

Antiretroviral treatment simplification with nevirapine in protease inhibitor-experienced patients with hiv-associated lipodystrophy: 1-year prospective follow-up of a multicenter, randomized, controlled study.

Ruiz L, Negredo E, Domingo P, Paredes R, Francia E, Balagué M, Gel S, Bonjoch A, Fumaz CR, Johnston S, Romeu J, Lange J, Clotet B; Spanish Lipodystrophy Group.

J Acquir Immune Defic Syndr. 2001 Jul 1;27(3):229-36.PMID: 11464141 [PubMed - indexed for MEDLINE]Related articles

The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group.

Haubrich RH, Little SJ, Currier JS, Forthal DN, Kemper CA, Beall GN, Johnson D, Dubé MP, Hwang JY, McCutchan JA.

AIDS. 1999 Jun 18;13(9):1099-107.PMID: 10397541 [PubMed - indexed for MEDLINE]Related articles

Virologic outcome and predictors of virologic failure of highly active antiretroviral therapy containing protease inhibitors.

Knobel H, Guelar A, Carmona A, Espona M, González A, López-Colomés JL, Saballs P, Gimeno JL, Díez A.

AIDS Patient Care STDS. 2001 Apr;15(4):193-9.PMID: 11359661 [PubMed - indexed for MEDLINE]Related articles

A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women.

Howard AA, Arnsten JH, Lo Y, Vlahov D, Rich JD, Schuman P, Stone VE, Smith DK, Schoenbaum EE; HER Study Group.

AIDS. 2002 Nov 8;16(16):2175-82.PMID: 12409739 [PubMed - indexed for MEDLINE]Related articles

Effect of adherence to newly initiated antiretroviral therapy on plasma viral load.

Gross R, Bilker WB, Friedman HM, Strom BL.

AIDS. 2001 Nov 9;15(16):2109-17.PMID: 11684930 [PubMed - indexed for MEDLINE]Related articles

Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies.

Braithwaite RS, Kozal MJ, Chang CC, Roberts MS, Fultz SL, Goetz MB, Gibert C, Rodriguez-Barradas M, Mole L, Justice AC.

AIDS. 2007 Jul 31;21(12):1579-89.PMID: 17630553 [PubMed - indexed for MEDLINE]Related articles

Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.

Verweel G, van Rossum AM, Hartwig NG, Wolfs TF, Scherpbier HJ, de Groot R.

Pediatrics. 2002 Feb;109(2):E25.PMID: 11826235 [PubMed - indexed for MEDLINE]Related articlesFree article

Gastrostomy tube insertion for improvement of adherence to highly active antiretroviral therapy in pediatric patients with human immunodeficiency virus.

Shingadia D, Viani RM, Yogev R, Binns H, Dankner WM, Spector SA, Chadwick EG.

Pediatrics. 2000 Jun;105(6):E80.PMID: 10835093 [PubMed - indexed for MEDLINE]Related articles

Similar adherence rates favor different virologic outcomes for patients treated with nonnucleoside analogues or protease inhibitors.

Maggiolo F, Ravasio L, Ripamonti D, Gregis G, Quinzan G, Arici C, Airoldi M, Suter F.

Clin Infect Dis. 2005 Jan 1;40(1):158-63. Epub 2004 Dec 6.PMID: 15614706 [PubMed - indexed for MEDLINE]Related articles

Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions.

Lucas GM, Chaisson RE, Moore RD.

Ann Intern Med. 1999 Jul 20;131(2):81-7.PMID: 10419445 [PubMed - indexed for MEDLINE]Related articlesFree article

Correlation between self-reported adherence to highly active antiretroviral therapy (HAART) and virologic outcome.

DeMasi RA, Graham NM, Tolson JM, Pham SV, Capuano GA, Fisher RL, Shaefer MS, Pakes GE, Sawyerr GA, Eron JJ Jr.

Adv Ther. 2001 Jul-Aug;18(4):163-73.PMID: 11697019 [PubMed - indexed for MEDLINE]Related articles

Quality of life, emotional status, and adherence of HIV-1-infected patients treated with efavirenz versus protease inhibitor-containing regimens.

Fumaz CR, Tuldrà A, Ferrer MJ, Paredes R, Bonjoch A, Jou T, Negredo E, Romeu J, Sirera G, Tural C, Clotet B.

J Acquir Immune Defic Syndr. 2002 Mar 1;29(3):244-53.PMID: 11873073 [PubMed - indexed for MEDLINE]Related articles

Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.

[No authors listed]

Prescrire Int. 2004 Aug;13(72):144-50.PMID: 15532140 [PubMed - indexed for MEDLINE]Related articles

Psychiatric illness and virologic response in patients initiating highly active antiretroviral therapy.

Pence BW, Miller WC, Gaynes BN, Eron JJ Jr.

J Acquir Immune Defic Syndr. 2007 Feb 1;44(2):159-66.PMID: 17146374 [PubMed - indexed for MEDLINE]Related articles

Predictors of virologic failure in HIV-1-infected patients starting highly active antiretroviral therapy in Porto Alegre, Brazil.

Tuboi SH, Harrison LH, Sprinz E, Albernaz RK, Schechter M.

J Acquir Immune Defic Syndr. 2005 Nov 1;40(3):324-8.PMID: 16249707 [PubMed - indexed for MEDLINE]Related articles

Pharmacy refill adherence compared with CD4 count changes for monitoring HIV-infected adults on antiretroviral therapy.

Bisson GP, Gross R, Bellamy S, Chittams J, Hislop M, Regensberg L, Frank I, Maartens G, Nachega JB.

PLoS Med. 2008 May 20;5(5):e109.PMID: 18494555 [PubMed - indexed for MEDLINE]Related articlesFree article

HIV-infected patients receiving lopinavir/ritonavir-based antiretroviral therapy achieve high rates of virologic suppression despite adherence rates less than 95%.

Shuter J, Sarlo JA, Kanmaz TJ, Rode RA, Zingman BS.

J Acquir Immune Defic Syndr. 2007 May 1;45(1):4-8.PMID: 17460469 [PubMed - indexed for MEDLINE]Related articles